Navigation Links


IGF at medicine products

IGF-1 EIA Endocrine Function 026-AC-27F1 Insulin Growth Factor

Description:Insulin-like growth factor 1 (IGF-1) is a polypeptide of 70 amino acids (7650 daltons), and is one of a number of related insulin-like growth factors present in the circulation. The molecule shows approximately 50% sequence homology with proinsulin and has a number of biological activities similar to insulin. The peptide is growth hormone (GH) dependent to a high degree, but there is growing evid...
Company:ALPCO Diagnostics

IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein

Description:IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein...
Company:ALPCO Diagnostics

Insulin-like Growth Factor-I (IGF-I) ELISA

Description:The IDS OCTEIATM IGF-I kit is a two-site ELISA for the quantitative determination of Insulin-like Growth Factor-I (IGF-I) in serum or plasma. The assay uses a highly specific polyclonal "capture" antibody in microtiter wells and a high affinity monoclonal antibody labelled with horseradish peroxidase. A simple sample pre-treatment replaces acid/ethanol extraction to provide for the direct immunoa...
Company:IDS Ltd

IMMULITE/IMMULITE 1000 IGF-I

Description:IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULITE systems can be found in a wide variety of immunoassay testing environments around the world....
Company:Siemens Medical Solutions Diagnostics

IMMULITE 2500 IGF-I

Description:IMMULITE 2500 is a high-throughput immunoassay system built around the many positive attributes of the IMMULITE 2000 with the important addition of Logic Driven Incubation (LDI). LDI technology allows assays to be designed for optimal performance with the fastest possible incubation times. This allows for critical assays such as the cardiac biomarkers and HCG to be run in around 15 mi...
Company:Siemens Medical Solutions Diagnostics

IMMULITE 2000 IGF-I

Description:IMMULITE 2000 assays are designed for use with the IMMULITE 2000, a high-throughput, continuous random access immunoassay analyzer. IMMULITE 2000 offers testing efficiency through centralization, and a rapidly expanding menu for effective patient management....
Company:Siemens Medical Solutions Diagnostics

IGF-I

Description:Insulin-like growth factor I or somatomedin-C, is a peptide highly dependent on growth hormone and has potent growth promoting activity. IGF-I is transported in serum by several IGF-binding proteins. In the diagnosis of growth disorders, measurements of IGF-I are a useful adjunct to assessment of growth hormone secretion. A normal plasma or serum IGF-I concentration is strong evidence against GH...
Company:Nichols Institute Diagnostics

IMMULITE/IMMULITE 1000 IGFBP-3

Description:IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULITE systems can be found in a wide variety of immunoassay testing environments around the world....
Company:Siemens Medical Solutions Diagnostics

IMMULITE 2000 IGFBP-3

Description:IMMULITE 2000 assays are designed for use with the IMMULITE 2000, a high-throughput, continuous random access immunoassay analyzer. IMMULITE 2000 offers testing efficiency through centralization, and a rapidly expanding menu for effective patient management....
Company:Siemens Medical Solutions Diagnostics

IGFBP-3

Description:IGFBP-3 contains 266 amino acids and is variably N-glycosylated. The variation accounts for its varying molecular weight estimates of between 43 and 56 kDa. Insulin-like growth factor binding proteins bind IGF-I and IGF-II with high affinity but do not bind insulin. Of the six distinct IGF binding proteins structurally characterized at this time, IGFBP-3 has been shown to be the major carrier of...
Company:Nichols Institute Diagnostics

Free IGF-I ELISA Test

Description:Insulin-like growth factor I (IGF-I or somatomedin C) is a 7.6 kDa peptide produced primarily in the liver. It acts as a potent mitogen of cellular proliferation, exerting its actions by binding to specific cell-surface receptors. In the circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), which appear to regulate the actions of IGF-I by modulating the interaction of IGF-I with the Type...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (Non-Extraction)

Description:Insulin-like growth factor I (IGF-I or somatomedin C) is a 7.6 kDa peptide produced primarily in the liver. It acts as a potent mitogen of cellular proliferation, exerting its actions by binding to specific cell-surface receptors. In the circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), which appear to regulate the actions of IGF-I by modulating the interaction of IGF-I with the Type...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (Non-Extraction)

Description:Insulin-like growth factor I (IGF-I or somatomedin C) is a 7.6 kDa peptide produced primarily in the liver. It acts as a potent mitogen of cellular proliferation, exerting its actions by binding to specific cell-surface receptors. In the circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), which appear to regulate the actions of IGF-I by modulating the interaction of IGF-I with the Type...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I ELISA Test (With Extraction)

Description:Insulin-like growth factor I (IGF-I or somatomedin C) is a 7.6 kDa peptide produced primarily in the liver. It acts as a potent mitogen of cellular proliferation, exerting its actions by binding to specific cell-surface receptors. In the circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), which appear to regulate the actions of IGF-I by modulating the interaction of IGF-I with the Type...
Company:Diagnostic Systems Laboratories, Inc.

IGF-I IRMA Test (With Extraction)

Description:Insulin-like growth factor I (IGF-I or somatomedin C) is a 7.6 kDa peptide produced primarily in the liver. It acts as a potent mitogen of cellular proliferation, exerting its actions by binding to specific cell-surface receptors. In the circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), which appear to regulate the actions of IGF-I by modulating the interaction of IGF-I with the Type...
Company:Diagnostic Systems Laboratories, Inc.

Free IGF-I IRMA Test

Description:Insulin-like growth factor I (IGF-I or somatomedin C) is a 7.6 kDa peptide produced primarily in the liver. It acts as a potent mitogen of cellular proliferation, exerting its actions by binding to specific cell-surface receptors. In the circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), which appear to regulate the actions of IGF-I by modulating the interaction of IGF-I with the Type...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-3 ELISA Test

Description:Human Insulin-like growth factor binding protein-3 (IGFBP-3) is the main binding protein for IGF-I and IGF-II in postnatal serum, as a component of the ~150 kDa ternary complex. This complex consists of IGFBP-3, a molecule of IGF-I or IGF-II and ALS, allowing IGFBP-3, along with ALS, to regulate the actions of the IGFs. The molar concentration of IGFBP-3 in normal serum is proportional to the mol...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-3 IRMA Test

Description:Human Insulin-like growth factor binding protein-3 (IGFBP-3) is the main binding protein for IGF-I and IGF-II in postnatal serum, as a component of the ~150 kDa ternary complex. This complex consists of IGFBP-3, a molecule of IGF-I or IGF-II and ALS, allowing IGFBP-3, along with ALS, to regulate the actions of the IGFs. The molar concentration of IGFBP-3 in normal serum is proportional to the mol...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, Non-Extraction ELISA Test

Description:Insulin-like growth factor II (IGF-II) is a 7.5 kDa peptide which is secreted primarily by the liver and is postulated to have mitogenic and metabolic actions involved in cellular growth. The actions of IGF-II are mediated by binding to target cell receptors. IGF-II binds with high affinity to the Type II IGF receptor, a monomeric protein which also serves as the receptor for mannose-6-phosphate...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, Non-Extraction IRMA Test

Description:Insulin-like growth factor II (IGF-II) is a 7.5 kDa peptide which is secreted primarily by the liver and is postulated to have mitogenic and metabolic actions involved in cellular growth. The actions of IGF-II are mediated by binding to target cell receptors. IGF-II binds with high affinity to the Type II IGF receptor, a monomeric protein which also serves as the receptor for mannose-6-phosphate...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, w/ Extraction ELISA Test

Description:Insulin-like growth factor II (IGF-II) is a 7.5 kDa peptide which is secreted primarily by the liver and is postulated to have mitogenic and metabolic actions involved in cellular growth. The actions of IGF-II are mediated by binding to target cell receptors. IGF-II binds with high affinity to the Type II IGF receptor, a monomeric protein which also serves as the receptor for mannose-6-phosphate...
Company:Diagnostic Systems Laboratories, Inc.

IGF-II, w/ Extraction IRMA Test

Description:Insulin-like growth factor II (IGF-II) is a 7.5 kDa peptide which is secreted primarily by the liver and is postulated to have mitogenic and metabolic actions involved in cellular growth. The actions of IGF-II are mediated by binding to target cell receptors. IGF-II binds with high affinity to the Type II IGF receptor, a monomeric protein which also serves as the receptor for mannose-6-phosphate...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-2 ELISA Test

Description:Human Insulin-like growth factor binding protein-2 (IGFBP-2) is one of six characterized IGFBPs (further IGFBPs have been proposed) which specifically bind and modulate the actions of IGF-I and IGF-II. The binding affinity of IGFBP-2 for IGF-II is estimated to be significantly higher than for IGF-I [1], suggesting a role in regulation of IGF-II action. Studies in the fetal sheep indicate that IGF...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-4 ELISA Test

Description:Insulin-like growth factor binding protein 4 (IGFBP-4) is a 24 kDa protein which specifically binds and modulates the actions of IGF-I and IGF-II. It is also present in a glycoslyated form with a molecular weight of 28 kDa. IGFBP-4 has been identified in all biological fluids, as well as in numerous cell types, including fibroblasts, neuroblastoma, prostate and bone cells [1,2]. IGFBP-4 appears t...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-2 RIA Test

Description:Human Insulin-like growth factor binding protein-2 (IGFBP-2) is one of six characterized IGFBPs (further IGFBPs have been proposed) which specifically bind and modulate the actions of IGF-I and IGF-II. The binding affinity of IGFBP-2 for IGF-II is estimated to be significantly higher than for IGF-I [1], suggesting a role in regulation of IGF-II action. Studies in the fetal sheep indicate that IGF...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-1, Total ELISA Test

Description:Human Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) is a phosphoprotein, produced primarily in the liver, which specifically binds and modulates the bioactivity of IGF-I and IGF-II [1]. The role of IGFBP-1 has not been completely defined, but the nature of its regulation suggests that IGFBP-1 may be involved in glucose regulation and IGF-mediated substrate utilization [1,2]. IGFBP-1 has...
Company:Diagnostic Systems Laboratories, Inc.

IGFBP-1, Total IRMA Test

Description:Human Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) is a phosphoprotein, produced primarily in the liver, which specifically binds and modulates the bioactivity of IGF-I and IGF-II [1]. The role of IGFBP-1 has not been completely defined, but the nature of its regulation suggests that IGFBP-1 may be involved in glucose regulation and IGF-mediated substrate utilization [1,2]. IGFBP-1 has...
Company:Diagnostic Systems Laboratories, Inc.

IGF Binding Protein-1

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

IGF Binding Protein-3

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

IGF Binding Protein 2

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

IGF-1 (Insulin-Like Growth Factor I)

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

IGFBP-2

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories

IGFBP-1

Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...
Company:ARUP Laboratories
Other TagsMarshfieldWeatherWeatherThompsonTrafficTrafficTrafficBusinesses
(Date:8/29/2008)...k of your biological clock may have just gotten a ...of Georgia report that the number of genes under c...ew years ago. The biological clock in a much-studi...iously reported. The new study implies that the cl...ing may help to explain why the clock is so far-re...
(Date:8/28/2008)... Radiation from the atomic bomb blasts in Hiroshi... chromosomes in some survivors who later developed...Japanese researchers. , In the September 1, 2008...rican Association for Cancer Research, the scienti...ast sites, were comparably young at the time, and ...
(Date:8/28/2008)...report the discovery of the first new living speci...port to be published online on August 28th in Cur...sil evidence reveals that the new species, called ...0 percent of giant clams in the Red Sea, it now re...ng there. , The researchers said they cannot say...
(Date:8/28/2008)...aican anole lizards begin and end the day with dis... and extensions of a colorful neck flap, or dewlap...study. , "Anoles are highly visual species, so i...use visual displays to mark territory," said Terry... at Harvard University,s Museum of Comparative Zoo...
Breaking Biology News(10 mins):Study shows more genes are controlled by biological clocks 2Study shows more genes are controlled by biological clocks 3Researchers discover atomic bomb effect results in adult-onset thyroid cancer 2New giant clam species offers window into human past 2Feats of strength begin a lizard's day 2Response Biomedical Corp Year End 2007 Earnings Webcast and Conference Call March 31 2008 14679 1Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections 4073 1Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections 4073 2Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections 4073 3bioMETRX Incorporates OKIs Fingerprint Engine in its smartTOUCH Product Line 2545 1bioMETRX Incorporates OKIs Fingerprint Engine in its smartTOUCH Product Line 2545 2bioMETRX Incorporates OKIs Fingerprint Engine in its smartTOUCH Product Line 2545 3PEMCO Insurance and Tullys Coffee Team Up to Make Coffee Orders Count For Childrens Hospital 14673 1PEMCO Insurance and Tullys Coffee Team Up to Make Coffee Orders Count For Childrens Hospital 14673 2PEMCO Insurance and Tullys Coffee Team Up to Make Coffee Orders Count For Childrens Hospital 14673 3
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
Other Contentscontagiosummolluscumspotsspotsspotsspotsspotsspotsspotsmonocytemoniliasismonomonomononeuropathy